Allergan Sales is an API and finished-dose manufacturer based in United States. It appears in 45 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), EDE (AE) and ARCSA (EC). Its GMP standing is certified by MFDS (Korea), US FDA and ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 3 September 2024 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Texas 76712, United Arab Emirates | Not on file |
| WACO, United States | Not on file |
| Irvine, United States | 2011068 |
| Campbell, United States | 3000720089 |
| Cincinnati, United States | 1523957 |
| Waco, United States | 1643525 |
| Molecule | Regulators | Docs |
|---|---|---|
| Ketorolac | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 24 | None |
| EDE (AE) | 12 | None |
| ARCSA (EC) | 4 | None |
| NPRA (MY) | 2 | None |
| DPM (TN) | 1 | None |
| MINSA (CR) | 1 | None |
| MFDS (Korea) | None | 2 |
| US FDA | None | 2 |
| ANVISA (Brazil) | None | 1 |
Choose your molecules and target markets. Allergan Sales comes back tiered against every other supplier able to file there.
Start for free